Issues lobbied + lobbyists (6)
BUD — Budget/Appropriations
FY27 funding for NIH. FY27 funding for VA Medical Research. FY27 funding for ARPA-H. FY27 funding for the Defense Medical Research. FY27 funding for the Agency for Healthcare Research and Quality. FY27 funding for the All of Us Research Program. FY27 funding for the CTSA program at NCATS.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
HCR — Health Issues
S.752, Accelerating Kids Access to Care Act. H.R.1262/S.932, Give Kids a Chance Act. Issues related to military-civilian medical training partnerships Issues related to the Rural Health Transformation Program. Issues related to expanding access in rural areas. Issues related to behavioral health.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
MED — Medical/Disease Research/Clinical Labs
H.R.7148, FY2026 Consolidated Defense, LHHSED, Nat. Sec.-State, THUD, FSGG Approps. Act, provisions related to medical research and public health funding. FY27 funding for NIH. FY27 funding for VA Medical Research. FY27 funding for ARPA-H. FY27 funding for the Defense Medical Research. FY27 funding for the Agency for Healthcare Research and Quality. FY27 funding for the All of Us Research Program. Issues related to indirect costs.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE; White House Office
MMM — Medicare/Medicaid
H.R.5269, the RESULTS Act. H.R.2005, the DMEPOS Relief Act. H.R.2902, the SOAR Act. H.R.5454/S.2879, Medicare Advantage Prompt Pay Act. H.R.6280/S.3607, the Access to Genetic Counselor Services Act. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act. Issues related to implementation of healthcare provisions in H.R.1. Issues related to CMS telehealth policies. Issues related to hospital outpatient reimbursement. Issues related to the Medicare area wage index. Issues related to Medicare Advantage. Issues related to Medicare GME. Issues related to Medicaid.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
PHA — Pharmacy
Issues related to the 340B discount drug program.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
IMM — Immigration
Issues related to visa policies for medical and scientific workforce.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE